Evanston Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Evanston Advisors's AMGN Position: Q4 2018 in Review
Evanston Advisors reduced its Amgen (AMGN) stake by 2.8% in Q4 2018, selling an estimated $257K and leaving 45,504 shares worth $8.86M. The position accounts for 2.41% of the portfolio, ranked #8.
Evanston Advisors first reported a position in AMGN in Q2 2017 and has held it in 7 quarters since. The position peaked at $9.71M in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.
- Evanston Advisors held 45,504 shares of Amgen worth $8.86M as of Q4 2018.
- Evanston Advisors sold 1,319 Amgen shares in Q4 2018, an estimated $257K.
- Amgen made up 2.41% of Evanston Advisors's portfolio in Q4 2018, its #8 holding.
- Evanston Advisors first reported a position in Amgen in Q2 2017 and has held it in 7 quarters since.
- Evanston Advisors's Amgen position peaked at $9.71M in Q3 2018.
- 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.
Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.